ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 169 filers reported holding ALKERMES PLC in Q2 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,000 | -46.2% | 983 | -24.1% | 0.00% | -100.0% |
| Q4 2019 | $26,000 | +4.0% | 1,295 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $25,000 | +4.2% | 1,295 | +22.4% | 0.00% | 0.0% |
| Q2 2019 | $24,000 | -38.5% | 1,058 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $39,000 | +11.4% | 1,058 | -11.8% | 0.00% | 0.0% |
| Q4 2018 | $35,000 | -92.7% | 1,199 | -89.4% | 0.00% | -90.9% |
| Q3 2018 | $479,000 | +6.2% | 11,281 | +3.0% | 0.01% | 0.0% |
| Q2 2018 | $451,000 | -62.4% | 10,957 | -47.1% | 0.01% | -63.3% |
| Q1 2018 | $1,200,000 | +7.3% | 20,710 | -5.8% | 0.03% | 0.0% |
| Q4 2017 | $1,118,000 | 0.0% | 21,990 | 0.0% | 0.03% | +3.4% |
| Q3 2017 | $1,118,000 | +0.7% | 21,990 | +14.8% | 0.03% | -6.5% |
| Q2 2017 | $1,110,000 | +85.9% | 19,147 | +87.7% | 0.03% | +82.4% |
| Q1 2017 | $597,000 | – | 10,202 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |